SEC Form 4 · accession 0001127602-15-016049
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward M Fitzgerald
Officer — Executive VP, CFO
Period of report
May 1, 2015
Accepted (ET)
May 4, 2015 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2015 | M | 60,000 | $7.56 | A | 365,852 | D | |
| Common Stock | May 1, 2015 | S | 60,000 | $8.80 | D | 305,852 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $7.56 | May 1, 2015 | M | 60,000 | D | Oct 4, 2006 | Oct 4, 2015 | Common Stock | 60,000 | 0 | D |
Explanation of responses
- F1Shares were acquired upon the exercise of outstanding stock options at $7.56 per share.
- F2This sale was pursuant to a 10b5-1 trading plan.
- F3Options vest 25% per year over 4 years.